发明名称 |
THERAPEUTIC CANCER VACCINE |
摘要 |
The present invention relates to polypeptide fragments capable of raising a specific T-cell response, wherein said fragment comprises a peptide consisti ng of at least 9 consecutive amino acid residues of ML-IAP as well as to said fragments for use as medicaments. The invention furthermore relates to use o f said polypeptide frag-ments in the manufacture of a medicament for treatment of a clinical condition, such as cancer. The invention also relates to metho ds of selecting a peptide comprising a fragment of ML-IAP for use in a vaccine composition as well as to vaccine composi-tions comprising isolated ML-IAP (SEQ ID NO:1) and/or one or more fragments thereof.
|
申请公布号 |
CA2563393(A1) |
申请公布日期 |
2004.10.21 |
申请号 |
CA20042563393 |
申请日期 |
2004.04.07 |
申请人 |
SURVAC APS |
发明人 |
STRATEN, PER THOR;ANDERSEN, MADS HALD |
分类号 |
C07K14/47;A61K38/17;A61K39/00;C07K16/30;C12N5/06 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|